Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts

W. P. Vaughan, A. W. Kimball, Judith Karp, L. H. Dragon, P. J. Burke

Research output: Contribution to journalArticle

Abstract

Eighteen patients referred to The Johns Hopkins Oncology Center for treatment of acute myelocytic leukemia during a 2-year period had pretreatment wbc counts > 50,000/μl. Despite immediate admission, aggressive supportive care, and rapid institution of chemotherapy, six patients died from complications of the high wbc count at presentation. The patients who died had significantly higher initial wbc counts, lower platelet counts, and lower arterial oxygen saturation; they were older, more likely to be female, and more likely to have abnormal serum urea nitrogen than the 12 patients who survived. Five of the six patients who died had experienced a delay of > 48 hours from diagnosis to referral, and only one of the 12 patients who survived was not promptly referred for treatment at the time of diagnosis (P = 0.004). A mathematical model, the logit of the fraction of the initial wbc count versus the logarithm of time after starting therapy, was used to describe the response of the wbc count to chemotherapy. This logit analysis reduced the data for individual patients to a linear function, permitting statistical description of the population as a whole. This statistical description makes possible the comparison of different approaches to lowering the wbc count in such patients and the correlation of rate of response of wbc count with the probability of achieving remission and with duration of remission.

Original languageEnglish (US)
Pages (from-to)1007-1013
Number of pages7
JournalCancer Treatment Reports
Volume65
Issue number11-12
StatePublished - 1981

Fingerprint

Acute Myeloid Leukemia
Survival
Drug Therapy
Platelet Count
Urea
Theoretical Models
Nitrogen
Therapeutics
Referral and Consultation
Oxygen
Serum
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Vaughan, W. P., Kimball, A. W., Karp, J., Dragon, L. H., & Burke, P. J. (1981). Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts. Cancer Treatment Reports, 65(11-12), 1007-1013.

Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts. / Vaughan, W. P.; Kimball, A. W.; Karp, Judith; Dragon, L. H.; Burke, P. J.

In: Cancer Treatment Reports, Vol. 65, No. 11-12, 1981, p. 1007-1013.

Research output: Contribution to journalArticle

Vaughan, WP, Kimball, AW, Karp, J, Dragon, LH & Burke, PJ 1981, 'Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts', Cancer Treatment Reports, vol. 65, no. 11-12, pp. 1007-1013.
Vaughan, W. P. ; Kimball, A. W. ; Karp, Judith ; Dragon, L. H. ; Burke, P. J. / Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts. In: Cancer Treatment Reports. 1981 ; Vol. 65, No. 11-12. pp. 1007-1013.
@article{81658d7e0edd474e8fa00d956c75eac2,
title = "Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts",
abstract = "Eighteen patients referred to The Johns Hopkins Oncology Center for treatment of acute myelocytic leukemia during a 2-year period had pretreatment wbc counts > 50,000/μl. Despite immediate admission, aggressive supportive care, and rapid institution of chemotherapy, six patients died from complications of the high wbc count at presentation. The patients who died had significantly higher initial wbc counts, lower platelet counts, and lower arterial oxygen saturation; they were older, more likely to be female, and more likely to have abnormal serum urea nitrogen than the 12 patients who survived. Five of the six patients who died had experienced a delay of > 48 hours from diagnosis to referral, and only one of the 12 patients who survived was not promptly referred for treatment at the time of diagnosis (P = 0.004). A mathematical model, the logit of the fraction of the initial wbc count versus the logarithm of time after starting therapy, was used to describe the response of the wbc count to chemotherapy. This logit analysis reduced the data for individual patients to a linear function, permitting statistical description of the population as a whole. This statistical description makes possible the comparison of different approaches to lowering the wbc count in such patients and the correlation of rate of response of wbc count with the probability of achieving remission and with duration of remission.",
author = "Vaughan, {W. P.} and Kimball, {A. W.} and Judith Karp and Dragon, {L. H.} and Burke, {P. J.}",
year = "1981",
language = "English (US)",
volume = "65",
pages = "1007--1013",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "11-12",

}

TY - JOUR

T1 - Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts

AU - Vaughan, W. P.

AU - Kimball, A. W.

AU - Karp, Judith

AU - Dragon, L. H.

AU - Burke, P. J.

PY - 1981

Y1 - 1981

N2 - Eighteen patients referred to The Johns Hopkins Oncology Center for treatment of acute myelocytic leukemia during a 2-year period had pretreatment wbc counts > 50,000/μl. Despite immediate admission, aggressive supportive care, and rapid institution of chemotherapy, six patients died from complications of the high wbc count at presentation. The patients who died had significantly higher initial wbc counts, lower platelet counts, and lower arterial oxygen saturation; they were older, more likely to be female, and more likely to have abnormal serum urea nitrogen than the 12 patients who survived. Five of the six patients who died had experienced a delay of > 48 hours from diagnosis to referral, and only one of the 12 patients who survived was not promptly referred for treatment at the time of diagnosis (P = 0.004). A mathematical model, the logit of the fraction of the initial wbc count versus the logarithm of time after starting therapy, was used to describe the response of the wbc count to chemotherapy. This logit analysis reduced the data for individual patients to a linear function, permitting statistical description of the population as a whole. This statistical description makes possible the comparison of different approaches to lowering the wbc count in such patients and the correlation of rate of response of wbc count with the probability of achieving remission and with duration of remission.

AB - Eighteen patients referred to The Johns Hopkins Oncology Center for treatment of acute myelocytic leukemia during a 2-year period had pretreatment wbc counts > 50,000/μl. Despite immediate admission, aggressive supportive care, and rapid institution of chemotherapy, six patients died from complications of the high wbc count at presentation. The patients who died had significantly higher initial wbc counts, lower platelet counts, and lower arterial oxygen saturation; they were older, more likely to be female, and more likely to have abnormal serum urea nitrogen than the 12 patients who survived. Five of the six patients who died had experienced a delay of > 48 hours from diagnosis to referral, and only one of the 12 patients who survived was not promptly referred for treatment at the time of diagnosis (P = 0.004). A mathematical model, the logit of the fraction of the initial wbc count versus the logarithm of time after starting therapy, was used to describe the response of the wbc count to chemotherapy. This logit analysis reduced the data for individual patients to a linear function, permitting statistical description of the population as a whole. This statistical description makes possible the comparison of different approaches to lowering the wbc count in such patients and the correlation of rate of response of wbc count with the probability of achieving remission and with duration of remission.

UR - http://www.scopus.com/inward/record.url?scp=0019840391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019840391&partnerID=8YFLogxK

M3 - Article

C2 - 6945910

AN - SCOPUS:0019840391

VL - 65

SP - 1007

EP - 1013

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 11-12

ER -